Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression (Q37308146)

19 August 2017

Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression (English)

1 reference

19 August 2017

0 references

1 reference

5

Bruce R Zetter

1 reference

19 August 2017

Adam S Feldman

1

1 reference

19 August 2017

Jacqueline Banyard

series ordinal

2

1 reference

19 August 2017

Chin-Lee Wu

series ordinal

3

1 reference

19 August 2017

W Scott McDougal

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

19 August 2017

Clinical Cancer Research

1 reference

19 August 2017

15

1 reference

19 August 2017

3

1 reference

19 August 2017

1024-1031

1 reference

19 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

What we could do now: molecular pathology of bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Urine based markers of urological malignancy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Evaluation of survival data and two new rank order statistics arising in its consideration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

The cystatins: Protein inhibitors of cysteine proteinases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Identification of cystatin B as a potential serum marker in hepatocellular carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Two molecular pathways to transitional cell carcinoma of the bladder.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Stefin B, the major low molecular weight inhibitor in ovarian carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Highly specific urine-based marker of bladder cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728013

Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome

20 October 2018

1 reference

12 December 2020

Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1

1 reference

12 December 2020

Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4

1 reference

12 December 2020

NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study

1 reference

12 December 2020

Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine

1 reference

12 December 2020

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

12 December 2020

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

12 December 2020

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

12 December 2020

Expression of cathepsin D in bladder carcinoma: correlation with pathological features and serum cystatin C levels

1 reference

12 December 2020

An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas

1 reference

12 December 2020

Partial allelotype of carcinoma in situ of the human bladder

1 reference

12 December 2020

Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma

1 reference

12 December 2020

Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines

1 reference

12 December 2020

Expression of Cysteine Protease Inhibitors Stefin A, Stefin B, and Cystatin C in Human Lung Tumor Tissue

1 reference

12 December 2020

Increased incidence of matrix metalloproteinases in urine of cancer patients

1 reference

12 December 2020

10.1158/1078-0432.CCR-08-1143

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19188175

1 reference